Hermann Schutt

Title: Hermann Schutt: Innovator in Enzymatic Processes

Introduction

Hermann Schutt is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of enzymatic processes, holding a total of 6 patents. His work primarily focuses on the development of therapeutic solutions for diabetes mellitus and other related conditions.

Latest Patents

Among his latest patents, Hermann Schutt has developed an improved process for the preparation of 1-desoxynojirimycin through enzymatic deacylation of acyl-aminosorboses. This compound can be further reacted by alkylation on the nitrogen atom to produce various saccharase inhibitors, which are therapeutically beneficial in treating diabetes mellitus. Another significant patent involves the stereoselective resolution of phenylglycine derivatives using enzymes. This process allows for the hydrolysis of ester or amide groups in N-acyl-L-phenylglycine esters or amides, leading to the separation of D-phenylglycine derivatives from their L-counterparts.

Career Highlights

Hermann Schutt is currently associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His innovative work has contributed to advancements in enzymatic applications, particularly in the medical field.

Collaborations

Hermann has collaborated with Michael Preiss, enhancing the research and development of enzymatic processes. Their partnership has led to significant advancements in the field.

Conclusion

Hermann Schutt's contributions to enzymatic processes and his innovative patents highlight his role as a key inventor in the pharmaceutical industry. His work continues to pave the way for new therapeutic solutions.